首页 > 市场调查报告书 > 医疗设备

病患监测

市场调查报告书

商品编码

1374798

全球心电图贴片与动态心电图监测仪市场 -2023-2030

Global ECG Patches and Holter Monitor Market -2023-2030

出版日期: 2023年11月01日 | 出版商:

DataM Intelligence | 英文 190 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

动态监测设备的趋势、该领域的技术进步、心律不整早期检测投资的增加以及遥测领域的进步将有助于市场在预测期内成长。心电图贴片是一种连接到体表（通常是胸部）的小型设备，用于处理、撷取和传输患者心臟活动的电讯号。

监视器中显示的资讯随后用于医疗诊断（动态心电图监视器）或用于显示健身活动中的心率等参数。如果传统心电图（ECG 或 EKG）无法提供有关心臟状况的足够详细信息，则可以进行动态心电图监测测试。如果不规则心跳不频繁，则可能需要称为事件记录器的长期监测器。

此外，全球心电图心律不整的盛行率不断上升、主要参与者推出新设备、与公司的併购、对动态监测设备的需求不断增加以及技术进步可能会在预测期内推动市场发展，并具有重要的关键角色诸如 Cardinal Health、Ambu、Hillrom (Baxter)、Nihon Kohden、Koninklijke Philips NV 等厂商。

动力学

心房颤动盛行率上升

心房颤动盛行率的上升是预测期内帮助市场成长的关键因素之一。普及率的提高将导致对心电图贴片和动态心电图监测设备的高需求。

例如，根据 NCBI 上发表的一篇最新文章，心房颤动是最常见的心律不整。心房颤动的盛行率在全世界不断增加。众所周知，心房颤动的盛行率通常随着年龄的增长而增加。据估计，到 2050 年，患有心房颤动的人数将增加一倍或三倍。

儘管全球心房颤动的盛行率约为 1%，但 75 岁以上的人中约有 9% 患有心房颤动。80 岁时，一生中罹患心房颤动的风险跃升至 22%。此外，心房颤动更常见于男性，且与黑人相比，在白人中更常见。

科技进步的崛起

技术进步的崛起是预测期内帮助市场成长的关键因素之一。该市场的进步之一是黏性单导联设备在过去 20 年中不断出现，作为一种改进的心电图远端监测方法。凭藉其不那么突兀的设计和长达 14 天的佩戴时间，这些生物感测器「贴片」技术已被证明在诊断心律不整方面优于动态心电图监测仪。 iRhythm (Zio) 的 ZIO 是用于检测心律不整的连续动态监测贴片技术的一个例子。此外，动态心电图技术已经发展了许多技术，该技术将有助于市场在预测期内的成长。

例如，2020 年 11 月，Vital Connect 宣布推出 VitalPatch RTM，这是第一个用于心臟监测的扩展动态心电图技术。 Vital Connect 推出了最新的心臟监测贴片 VitalPatch RTM，适合需要扩展动态心电图监测的患者。这款穿戴式生物感测器透过使用人工智慧心电图感测器来寻找 21 种不同的心律不整。它持续监测四个重要的生命征象：心率、心率变异性、呼吸频率和活动。

繁琐且过时的动态心电图分析

传统的动态心电图分析由心臟科医生手动进行，非常复杂并且需要大量的努力。进行动态心电图检查时，护理师必须将动态心电图设备的原始讯号上传到计算机，然后医生根据他们目前的知识和经验创建报告。因此，医生需要经验丰富、精确且警惕，才能正确准备这样的报告。

The trend towards ambulatory monitoring devices, technological advancements in the field, increase in investments for early detection of arrhythmia, and advancements in the field of telemetry will help the market to grow during the forecast period. The ECG patch is a small device that is connected to the body surface (commonly the chest) to process, acquire and transmit the electrical signal of the patient's heart activity.

The information which was shown in monitor is later used for medical diagnostics (Holter monitors) or for displaying parameters such as heart rate in fitness activities. A Holter monitor test may be done if a traditional electrocardiogram (ECG or EKG) doesn't provide enough details about the heart's condition. If the irregular heartbeats are infrequent, a longer-term monitor called an event recorder may be needed.

Furthermore, the global ECG The Growing prevalence of cardiac arrhythmia, new device launches by key players, mergers and acquisitions with the companies, increasing demand for ambulatory monitoring devices, and technological advancements are likely to drive the market during the forecast period with having significant key players like Cardinal Health, Ambu, Hillrom (Baxter), Nihon Kohden, Koninklijke Philips N.V and others.

Dynamics

Rise in the Prevalence of Atrial Fibrillation

The rise in the prevalence of atrial fibrillation is one of the key factors that help the market to grow during the forecast period. Increase the prevalence will lead to high demand for ECG Patches and Holter monitor devices.

For instance, according to an updated article published in NCBI Atrial fibrillation is the most commonly encountered cardiac rhythm disorder. The prevalence of atrial fibrillation has been increasing worldwide. It is known that the prevalence of atrial fibrillation generally increases with age. It has been estimated that the number of individuals with atrial fibrillation will double or triple by the year 2050.

Although the worldwide prevalence of atrial fibrillation is approximately 1%, it is found in approximately 9% of individuals over the age of 75. At the age of 80, the lifetime risk of developing atrial fibrillation jumps to 22%. In addition, atrial fibrillation has more commonly been associated with males and is seen more often in whites as compared to blacks.

Rise in the Technological Advancements

The rise in the technological advancements is one of the key factors that helps the market to grow during the forecast period. One of the advancements in this market was Adhesive single-lead devices have been emerging over the last 20 years as an improved method of ECG remote monitoring. With their less obtrusive design and wear time of up to 14 days, these biosensor 'patch' technologies have been shown to outperform Holter monitors in diagnosing cardiac arrhythmias. ZIO by iRhythm (Zio) is an example of a continuous ambulatory monitoring patch technology used to detect cardiac arrhythmias. Also, numerous technologies have been evolved in Holter Technology and this technology will help the market to grow during the forecast period.

For instance, in November 2020 Vital Connect announced the Launch of VitalPatch RTM, a first-of-its-kind extended holter technology for cardiac monitoring. Vital Connect has launched its latest cardiac monitoring patch, the VitalPatch RTM, for patients who require extended Holter monitoring. The wearable biosensor looks for 21 different cardiac arrhythmias by using an artificial intelligence electrocardiogram sensor. It continuously monitors four significant vital signs: heart rate, heart rate variability, respiratory rate and activity.

Tedious And Outdated Holter ECG Analysis

Traditional Holter ECG analysis conducted manually by a cardiologist is complicated and requires a lot of effort. When a Holter examination is carried out, the nurse has to upload the raw signal from the Holter device to a computer, and then the physician creates their report, based on their current knowledge and experience. Thus, the doctor needs to be experienced, precise, and vigilant to be able to prepare such a report correctly.

Segment Analysis

The global ECG Patches and Holter Monitor market is segmented based on device type, application, end-user and region.

The ECG Patches Segment From the Device Type Segment Accounted For Approximately 41.7% of ECG Patches and Holter Monitor Share

The ECG Patches segment from the device type segment accounted for 41.7% and it is expected to be dominated during the forecast period. A wearable ECG patch is equipped with an electrocardiography sensor and accelerometer to detect and record physiological data. Similar to smartwatches, ECG patches can be synced with a device such as a phone or a tablet to display the results.

For instance, in May 2023, VTT Technical Research Centre of Finland developed a new sustainable electrocardiogram (ECG, also known as EKG) patch that is fully recyclable and made of biomaterials. The device is modular, so electronic components can be easily removed from the disposable patch and used again.

The patch itself is made of nanocellulose and printed with carbon conductors and sensing electrodes. The biodegradable patch is made of VTT's new material cellulose e-skin, which replaces traditional plastic in wearable skin applications.

Furthermore, in August 2022 SmartCardia, a leading MedTech company dedicated to strengthening the healthcare ecosystem, launched 7L patch, their 7-lead Cardiac Monitoring Patch in India. This state-of-the-art patch monitor combines medical wearable technology with AI to provide predictive and personalized patient insights through remote monitoring. The 7L patch is tracked by SmartCardia's AI platform which is developed from millions of ECG segments interpreted by cardiologists and certified cardiac technicians and performs real-time detection of important arrhythmia events at cardiologist level accuracy.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to the rising incidence of Atrial Fibrillation in the region, ageing population, technological advancements, mergers and acquisitions, shifting patient preference toward ambulatory ECG monitoring, the launch of next-generation wireless ECG monitoring devices, and technological collaborations between manufacturers.

For instance, in January 2021, Boston Scientific announced that it has entered into a definitive agreement to acquire Preventice Solutions, Inc., a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors - including short and long-term Holter monitors - to cardiac event monitors and mobile cardiac telemetry. The transaction consists of an upfront cash payment of $925 million, and up to an additional $300 million in a potential commercial milestone payment.

Competitive Landscape

The major global players in the market include: Cardinal Health, Ambu, Hillrom (Baxter), Nihon Kohden, Koninklijke Philips N.V., Koninklijke Philips N.V., SCHILLER, GE Healthcare, Henry Schein, Spacelabs Healthcare and among others.

COVID-19 Impact Analysis

COVID-19 has positively impacted the market by increasing the use of ECG patches and Holter monitor devices for diagnosing, evaluating, and treating cardiac conditions. Patients with rhythm monitoring therapy are at a higher risk of developing severe diseases, leading to increased demand and growth in the market.

Also, the COVID-19 pandemic has resulted in high burden on public health and healthcare delivery globally. The disease has major effects on the cardiovascular system. A wide range of arrhythmias have been reported in patients, which complicate the course of COVID-19 due to the associated treatments.

Key Developments

In May 2023 Vivalink, a leading provider of digital healthcare solutions, stated the newest version of its multi-parameter wearable electrocardiogram (ECG) patch with continuous 14-day live stream capabilities. With Vivalink's new patch, extended duration remote ECG monitoring can be performed with a single application of the patch, thereby reducing both clinician and patient burden. In addition, the real-time streaming capabilities let clinicians remotely view a patient's live ECG anywhere anytime.
In October 2022 Dozee, a healthcare startup that provides contactless remote patient- monitoring launched an easy-to-use ambulatory electrocardiogram (ECG) patch to monitor patients with cardiovascular disease (CVD). This ECG patch is to augment and play a key role in assisting health care professionals (HCPs) in identifying early signs of cardiac deterioration ensuring there is timely medical intervention, thereby improving patient safety.
In April 2022 B-Secur stated the launch of the FDA-cleared next-generation ECG cloud-based platform for use across Holter monitors, wearables and implantable devices. According to a company press release, the cloud-based software (Heart Key 2.0) reduces ECG signal noise, improving ECG interpretation for clinicians and facilitating the trend towards remote cardiac monitoring.

Why Purchase the Report?

To visualize the global ECG Patches and Holter Monitor market segmentation based on device type, application, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global ECG Patches and Holter Monitor market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global ECG patches and Holter monitor market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Device Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Prevalence of Atrial Fibrillation
  - 4.1.1.2. Rise in the Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Tedious And Outdated Holter ECG Analysis
- 4.1.3. Opportunity
  - 4.1.3.1. Rise in the Product Launches in Emerging Markets
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Device Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 7.1.2. Market Attractiveness Index, By Device Type
7.2. ECG Patches*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Holter Monitor

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Monitoring *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Diagnostics

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Specialty Clinics
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Cardinal Health*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Ambu
12.3. Hillrom (Baxter)
12.4. Nihon Kohden
12.5. Koninklijke Philips N.V.
12.6. Koninklijke Philips N.V.
12.7. SCHILLER
12.8. GE Healthcare
12.9. Henry Schein
12.10. Spacelabs Healthcare

LIST NOT EXHAUSTIVE